Reckitt Benckiser Group stock

RKT · LSE · GBp

Compare Reckitt Benckiser Group
5,778.00 GBpChange from previous close: +1.33%Absolute change: +76.00 GBp

Close · November 16, 2026

Price history

−5.89% over the period

1 year: from 6,137.50 GBp (November 17, 2025) to 5,776.00 GBp (November 16, 2026), −5.89%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 16, 20265,776.00 GBp
October 30, 20265,408.00 GBp
September 30, 20264,992.00 GBp
August 28, 20265,132.00 GBp
July 31, 20265,240.00 GBp
June 30, 20264,911.00 GBp
May 29, 20264,591.00 GBp
April 30, 20264,678.00 GBp
March 31, 20265,088.00 GBp
February 27, 20266,512.00 GBp
January 30, 20266,345.83 GBp
December 31, 20256,252.08 GBp
November 28, 20256,095.83 GBp
November 17, 20256,137.50 GBp

At a glance

  • The company

    Manufactures and sells health, hygiene, and nutrition products including germ protection, wellness, over-the-counter medicines, personal care, vitamins, and infant nutrition

  • Latest results

    Quarter to June 30, 2026 · EPS £1.01 (estimate £1.48)

TickerLandia's take on Reckitt Benckiser Group

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low3,664.00 GBp
52-wk high6,522.92 GBp

−11.42% from the 52-week high

Analysts · 19 analysts

Average target6,270.11 GBp+8.52% vs. price

Buy 15 · Hold 4 · Sell 0 · Buy

TickerLandia Fingerprint: Reckitt Benckiser Group

Compared with similar companies: very low growth and very low financial strength.

Financials and price compared with 27 companies in the household & personal products industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Reckitt Benckiser Group is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2025), Reckitt Benckiser Group's P/E today is 11.8, below the median of its last 8 fiscal years (21.7; between 12.8 and 41.1 from 2016 to 2025). Reckitt Benckiser Group's P/E (trailing 12 months): 13.0, −33% against the median of a group of 11 similar companies (19.6).

P/E compared with its history

Compared with 11 similar companies

Reckitt Benckiser Group's metrics compared with similar companies
MetricReckitt Benckiser GroupPosition in the groupBand
P/E (trailing 12 months)13.0Low
Forward P/E16.3Middle
Operating margin22.7%High
ROE48.0%High
Debt/equity1.80High

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Reckitt Benckiser Group. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

£6.41B

Latest quarter · Q2 2026

Net income

£652M

Latest quarter · Q2 2026

Quarterly net margin

10.2%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
£36.61B
P/E
13.0
EPS
444.00 GBp
Volume
24.29K
Daily trading
€95.53M
Dividend yield
3.75%
Last ex-dividend on August 6, 2026

How Reckitt Benckiser Group is changing

All results
  • Revenue grew 0.3% a year on average over the last 5 years

  • Profits turn into cash: free cash flow equal to 102% of net income

  • Shares outstanding down 4.6% in 5 years

Returns

Reckitt Benckiser Group returns with dividends

£1,000 invested in Reckitt Benckiser Group 5 years ago, on November 16, 2021, would be worth £1,122 today with dividends reinvested: +12.17% in total, +2.32% per year. On price alone it would be £897 (−10.30%).

PeriodReckitt Benckiser GroupFTSE 100£1,000 becomes
1 month+3.44%+0.53%£1,034
6 months+25.69%+7.30%£1,257
Year to date−7.61%+10.15%£924
1 year+1.79%+13.07%£1,018
3 years+21.90%+47.62%£1,219
5 years+12.17%+49.31%£1,122
10 years+14.71%+62.08%£1,147

Over the last 6 months it has done better than 73% of the stocks in the Consumer sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. FTSE 100: price only. Calculate your investment

The chart in detail

Reckitt Benckiser Group: technical analysis

Reckitt Benckiser Group shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 31.6% below its highest close since January 1, 1990 (8,445.83 GBp, June 6, 2017).

Trend
No clear trend
RSI (14 sessions)
67
Between 30 and 70
vs 200-session average
+11.18%

Active signals

  • Close above the high of the previous 55 sessions.

  • Golden cross: the 50-session average has crossed above the 200-session average.

    since November 10, 2026

Support and resistance

Price areas where Reckitt Benckiser Group has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance6,516.52 GBp+12.78%3 touches, last on February 27, 2026
  2. Resistance6,300.69 GBp+9.05%3 touches, last on December 19, 2025
  3. Last price5,778.00 GBp
  4. Support5,651.00 GBp−2.20%2 touches, last on October 23, 2026
  5. Support5,421.00 GBp−6.18%2 touches, last on September 1, 2026
  6. Support5,139.00 GBp−11.06%2 touches, last on September 15, 2026

Volatility and risk

Over the last year it has moved roughly in line with the FTSE 100.

Beta (1 year) vs FTSE 100
0.89
Volatility (60 sessions, annualised)
25.8%
Largest fall in the last year
−31.77%

Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Reckitt Benckiser Group: seasonality

Average monthly price change over 37 years

+0.3%Jan+1.6%Feb−0.2%Mar+2.2%Apr+1.1%May−0.6%Jun+2.9%Jul−0.5%Aug+0.2%Sep+1.3%Oct−0.9%Nov+1.2%Dec

Over the last 37 years, the strongest month for Reckitt Benckiser Group has been July: +2.93% on average, positive in 26 years out of 37. The weakest has been November: −0.86% on average, positive in 18 years out of 36.

Show chart data
MonthAverageMedianPositive years
January+0.26%−0.28%18 of 36
February+1.59%+3.08%25 of 37
March−0.16%+1.44%21 of 37
April+2.16%+1.83%24 of 37
May+1.07%+0.45%20 of 37
June−0.64%−1.53%16 of 37
July+2.93%+2.84%26 of 37
August−0.48%+0.29%21 of 37
September+0.16%+0.51%21 of 37
October+1.26%+0.44%19 of 37
November−0.86%−0.18%18 of 36
December+1.22%+1.63%25 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Reckitt Benckiser Group and its competitors

Consumers in the United Kingdom and in markets around the world buy the health, hygiene and nutrition products sold by Reckitt Benckiser Group plc. The range runs from over-the-counter medicines such as Nurofen, Gaviscon, Strepsils and Mucinex, and intimate wellness brands Durex and KY, to germ protection under Dettol and home cleaning and disinfectants under Finish, Harpic and Lysol. The company also sells stain removal under Vanish, personal care under Clearasil and Veet, vitamins and supplements under MegaRed, Airborne, Movefree and neuriva, and infant and young children's nutrition under Enfamil and Nutramigen.

Headquarters
Slough, United Kingdom
Employees
36,200
Founded
1819
Chief executive
Kristoffer Licht
Reckitt Benckiser Group and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Reckitt Benckiser GroupRKT$48.42B22.7%13.0+25.69%
Henkel & Kgaa PrefHEN3$35.06B13.9%16.7+36.53%
BeiersdorfBEI$20.34B13.6%19.6+19.13%
EssityESSITY.B$19.76B13.0%18.1+18.42%
UnileverULVR$142.05B20.0%13.5+19.99%
Puig BrandsPUIG$12.7B16.6%19.8+17.13%

Same industry or related industries, similar size. Compare Reckitt Benckiser Group with its competitors · Full profile